Top Markets
#1 TENDIES TENDIES +42.31%
#2 Cash Cat Cash Cat +24.22%
#3 Asteroid Shiba Asteroid Shiba +16.17%
#4 OSK OSK +15.36%
#5 龙虾 (Lobster) 龙虾 (Lobster) +10.93%
#6 Bluwhale Bluwhale +10.55%
#7 MarsCoin MarsCoin +8.17%
#8 Threshold Network Threshold Network +7.55%
#9 Pyth Network Pyth Network +7.25%
#10 Tornado Cash Tornado Cash +6.90%
Coin of the day
TENDIES TENDIES
Settings
Language
ENGLISH
Currency
USD
Theme
Spectral Medical Inc. Spectral Medical Inc.

Spectral Medical Inc.

EDT
Rank in Stocks #16672
Spectral Medical Inc. focuses on the development and commercialization of... Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Share Price
$0.95411796
Last synced: 2026-09-01
Market Cap
$279.96M
Change (1 day)
-0.76%
Change (1 year)
-16.23%
Country
CA
Trade Spectral Medical Inc. (EDT)

Category

Healthcare
P/E ratio for Spectral Medical Inc. (EDT)
P/E ratio as of 2026 TTM: 0
According to Spectral Medical Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Spectral Medical Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 33.14 -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 37.80 -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 -236.74 -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 39.09 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.